Table of Contents

Cancer Therapy: Preclinical

• Cancer Therapy: Preclinical

  Selective Cytotoxicity to HER2-Positive Tumor Cells by a Recombinant e23sFv-TD-tBID Protein Containing a Furin Cleavage Sequence

  Fang Wang, Jing Ren, Xiu-Chun Qiu, Li-Feng Wang, Qing Zhu, Ying-Qi Zhang, Yi Huan, Yan-Ling Meng, Li-Bo Yao, Si-Yi Chen, Yan-Ming Xu and An-Gang Yang

  Clin Cancer Res April 15 2010 16 (8) 2284-2294; DOI:10.1158/1078-0432.CCR-09-2367

  
  
• Cancer Therapy: Preclinical

  CK2 Modulation of NF-κB, TP53, and the Malignant Phenotype in Head and Neck Cancer by Anti-CK2 Oligonucleotides In vitro or In vivo via Sub–50-nm Nanocapsules

  Matthew S. Brown, Oumou T. Diallo, Michael Hu, Reza Ehsanian, Xinping Yang, Pattatheyil Arun, Hai Lu, Vicci Korman, Gretchen Unger, Khalil Ahmed, Carter Van Waes and Zhong Chen

  Clin Cancer Res April 15 2010 16 (8) 2295-2307; DOI:10.1158/1078-0432.CCR-09-3200

  
  
• Cancer Therapy: Preclinical

  Targeted Cytosine Deaminase-Uracil Phosphoribosyl Transferase Suicide Gene Therapy Induces Small Cell Lung Cancer–Specific Cytotoxicity and Tumor Growth Delay

  Camilla L. Christensen, Torben Gjetting, Thomas T. Poulsen, Frederik Cramer, Jack A. Roth and Hans S. Poulsen

  Clin Cancer Res April 15 2010 16 (8) 2308-2319; DOI:10.1158/1078-0432.CCR-09-3057

  
  
• Cancer Therapy: Preclinical

  Histone Deacetylase Inhibitors and 15-Deoxy-Δ^12,14-Prostaglandin J₂ Synergistically Induce Apoptosis

  Makoto Koyama, Yasuyuki Izutani, Ahmed E. Goda, Taka-aki Matsui, Mano Horinaka, Mitsuhiro Tomosugi, Jun Fujiwara, Yoshitaka Nakamura, Miki Wakada, Shingo Yogosawa, Yoshihiro Sowa and Toshiyuki Sakai

  Clin Cancer Res April 15 2010 16 (8) 2320-2332; DOI:10.1158/1078-0432.CCR-09-2301

  
  
• Cancer Therapy: Preclinical

  T-Cell Receptor Gene–Modified T Cells with Shared Renal Cell Carcinoma Specificity for Adoptive T-Cell Therapy

  Matthias Leisegang, Adriana Turqueti-Neves, Boris Engels, Thomas Blankenstein, Dolores J. Schendel, Wolfgang Uckert and Elfriede Noessner

  Clin Cancer Res April 15 2010 16 (8) 2333-2343; DOI:10.1158/1078-0432.CCR-09-2897

  
  
• Cancer Therapy: Preclinical

  Development of a Functional Assay for Homologous Recombination Status in Primary Cultures of Epithelial Ovarian Tumor and Correlation with Sensitivity to Poly(ADP-Ribose) Polymerase Inhibitors

  Asima Mukhopadhyay, Ahmed Elattar, Aiste Cerbinskaite, Sarah J. Wilkinson, Yvette Drew, Suzanne Kyle, Gerrit Los, Zdenek Hostomsky, Richard J. Edmondson and Nicola J. Curtin

  Clin Cancer Res April 15 2010 16 (8) 2344-2351; DOI:10.1158/1078-0432.CCR-09-2758

  
  
• Cancer Therapy: Preclinical

  Establishment and Characterization of a Panel of Human Uveal Melanoma Xenografts Derived from Primary and/or Metastatic Tumors

  Fariba Némati, Xavier Sastre-Garau, Cécile Laurent, Jérôme Couturier, Pascale Mariani, Laurence Desjardins, Sophie Piperno-Neumann, Olivier Lantz, Bernard Asselain, Corine Plancher, Delphine Robert, Isabelle Péguillet, Marie-Hélène Donnadieu, Ahmed Dahmani, Marie-Andrée Bessard, David Gentien, Cécile Reyes, Simon Saule, Emmanuel Barillot, Sergio Roman-Roman and Didier Decaudin

  Clin Cancer Res April 15 2010 16 (8) 2352-2362; DOI:10.1158/1078-0432.CCR-09-3066

  
  
• Cancer Therapy: Preclinical

  Preclinical Evidence that Use of TRAIL in Ewing's Sarcoma and Osteosarcoma Therapy Inhibits Tumor Growth, Prevents Osteolysis, and Increases Animal Survival

  Gaëlle Picarda, François Lamoureux, Loïc Geffroy, Pascal Delepine, Tristan Montier, Karine Laud, Franck Tirode, Olivier Delattre, Dominique Heymann and Françoise Rédini

  Clin Cancer Res April 15 2010 16 (8) 2363-2374; DOI:10.1158/1078-0432.CCR-09-1779